R&D Paving the road to functionally active antibody drugs Antibody drugs have reshaped how we treat diseases.
R&D Prediction is very difficult, especially if it’s about the f... In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acceleration of antibody therapeutics.
News Regeneron's Inmazeb named Galien's Best Biotech Product The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded its
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
